Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2003
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157094 Prevention, therapy liver disorders, inflammatory bowel diseases, Crohn's disease; antiulcer agents; rheumatic diseases
08/21/2003US20030157087 Gastrointestinal disorders
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157079 Adhesion to mucous membranes; cell proliferation; prevention, therapy of digestion diseases
08/21/2003US20030156972 Irradiation of ispaghula
08/21/2003CA2476424A1 Means and methods for altering the motility of the gastrointestinal tract
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476162A1 Jnk inhibitor
08/21/2003CA2476113A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475825A1 Tricyclic n-acyl compounds
08/21/2003CA2475783A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003CA2475770A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn.gamma.g(g)
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2475659A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
08/21/2003CA2475439A1 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2472763A1 5-ht2b receptor antagonists
08/21/2003CA2472762A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003CA2472603A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336408A1 Water-soluble liquid internal medicine
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335912A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
08/20/2003EP1335907A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335720A1 Sulphonamides for the treatment of central nervous system diseases
08/20/2003EP1335716A1 Novel use of combined 5-ht 1a agonists and selective serotonin reuptake inhibitors
08/20/2003EP1335709A2 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole
08/20/2003EP1335706A2 Microspheres of pancreatic enzymes with high stability
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1254139B1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1128819B1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1075258B1 Novel fatty analogues for the treatment of obesity
08/20/2003EP1070037B1 Anti-inflammatory, antibacterial benzyl phenol agents
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0966295B1 Calcareous material
08/20/2003EP0934058B1 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437602A Compounds for treating impaired fundic relaxation
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437598A Novel indole derivatives
08/20/2003CN1437593A Novel amorphous form of omeprazole salts
08/20/2003CN1437592A Process for producing crystal
08/20/2003CN1437591A Compounds and methods for modulation of estrogen receptors
08/20/2003CN1437585A Method and compositions utilizing quinazolinones
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1437470A COX-2 inhibitors and the preventionof the side effects of radiation therapy
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1436570A Production process and application of improved human alpha-interferon
08/20/2003CN1436566A Colic disease treating medicine bolus
08/20/2003CN1436560A Kidney and spleen invigorating Chinese medicine beverage for delaying senility
08/20/2003CN1436551A Tea polyphenol containing nourishing capsule
08/20/2003CN1436545A Medicine and prepn for treating children's diarrhea
08/20/2003CN1436529A Medicine prepn for treating gastrointestial tract reaction caused by chemotherapy
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118464C Novel pyrimidine derivatives and process producing the same
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/20/2003CN1118460C Pyrimidine derivatives as 5HT2C-receptor antagonists
08/20/2003CN1118452C 1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, its producing process medicinal composition containing the same compound and intermediate of the compound
08/20/2003CN1118298C Health product instant granules and producing method thereof
08/20/2003CN1118295C Chinese herb medicine composition with kidney-reinforcing and blood circulation-promoting function
08/20/2003CN1118294C Preparation of medicine fo treating stomach diseases
08/20/2003CN1118287C Health-care medicine
08/20/2003CN1118286C Oral medicine for treating gastroenteristic diseases and its preparation
08/20/2003CN1118283C Gastropathy treating medicine and its prepn.
08/20/2003CN1118278C Application of ursolic acid in medicine for treating viral hepatitis
08/19/2003US6608197 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
08/19/2003US6608191 Antisense oligonucleotide of given sequence; capable of inhibiting the function of viral RNA
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608102 Urinary tract infections caused by P-type Escherichia coli
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608092 Crystals of benzimidazole compounds
08/19/2003US6608087 Gyrase inhibitors and uses thereof
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608067 Inhibitors of serine proteases, particularly HCV NS3 protease
08/19/2003US6608044 Inhibition of TNF activity
08/19/2003US6608033 Treatment or prevention of coccidiosis
08/19/2003US6608030 Inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
08/19/2003US6608029 Reducing gastric motility or delaying gastric emptying in mammal by administering therapeutically effective amount of amylin or amylin agonist, such as pramlintide or pramlintide acetate
08/19/2003US6607749 Non-fermentable methyl cellulose, lipase inhibitor and edible calcium phosphate salt; fecal incontinence, obesity
08/19/2003US6607743 Milk-derived basic cystatins or decomposition products; foods, beverages, feeds
1 ... 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 ... 1258